These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


172 related items for PubMed ID: 15022182

  • 1. Objective assessment of motor slowness in Huntington's disease: clinical correlates and 2-year follow-up.
    van Vugt JP, Piet KK, Vink LJ, Siesling S, Zwinderman AH, Middelkoop HA, Roos RA.
    Mov Disord; 2004 Mar; 19(3):285-97. PubMed ID: 15022182
    [Abstract] [Full Text] [Related]

  • 2. Complex movement behaviour and progression of Huntington's disease.
    Andrich J, Saft C, Ostholt N, Müller T.
    Neurosci Lett; 2007 Apr 18; 416(3):272-4. PubMed ID: 17321683
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Huntington chorea. Clinical correlations and preliminary neuropsychological data].
    Fragassi NA, Stanzione M, Angelini R, Di Maio L.
    Acta Neurol (Napoli); 1992 Apr 18; 14(4-6):530-6. PubMed ID: 1293994
    [Abstract] [Full Text] [Related]

  • 5. Bradykinesia in Huntington's disease. A prospective, follow-up study.
    García Ruiz PJ, Hernández J, Cantarero S, Bartolomé M, Sánchez Bernardos V, García de Yébenez J.
    J Neurol; 2002 Apr 18; 249(4):437-40. PubMed ID: 11967649
    [Abstract] [Full Text] [Related]

  • 6. Correlates of early disability in Huntington's disease.
    Mayeux R, Stern Y, Herman A, Greenbaum L, Fahn S.
    Ann Neurol; 1986 Dec 18; 20(6):727-31. PubMed ID: 2949692
    [Abstract] [Full Text] [Related]

  • 7. Effects of rivastigmine on motor and cognitive impairment in Huntington's disease.
    de Tommaso M, Specchio N, Sciruicchio V, Difruscolo O, Specchio LM.
    Mov Disord; 2004 Dec 18; 19(12):1516-8. PubMed ID: 15390067
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Two years' follow-up of rivastigmine treatment in Huntington disease.
    de Tommaso M, Difruscolo O, Sciruicchio V, Specchio N, Livrea P.
    Clin Neuropharmacol; 2007 Dec 18; 30(1):43-6. PubMed ID: 17272969
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sleep and circadian rhythm alterations correlate with depression and cognitive impairment in Huntington's disease.
    Aziz NA, Anguelova GV, Marinus J, Lammers GJ, Roos RA.
    Parkinsonism Relat Disord; 2010 Jun 18; 16(5):345-50. PubMed ID: 20236854
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Assessment of simple movements reflects impairment in Huntington's disease.
    Saft C, Andrich J, Meisel NM, Przuntek H, Müller T.
    Mov Disord; 2006 Aug 18; 21(8):1208-12. PubMed ID: 16700032
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Functional decline in Huntington's disease.
    Feigin A, Kieburtz K, Bordwell K, Como P, Steinberg K, Sotack J, Zimmerman C, Hickey C, Orme C, Shoulson I.
    Mov Disord; 1995 Mar 18; 10(2):211-4. PubMed ID: 7753064
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.